We are proudly presenting Mitis as 4th exhibitor at the ISTEGIM Symposium.

Mitis is high-tech startup active in the field of clean energy technology development. Mitis was founded by Dr Michel Delanaye, started its activities in 2012 and is located on the campus of the University of Liège in Belgium. Shareholders are its main founder, private investors and the public-private investment company Meusinvest through its subsidiary Sart-Up Invest. 

We are proudly presenting KNMF as third exhibitor at the ISTEGIM Symposium.

KNMF is a high-tech platform for structuring and characterizing a multitude of functional materials at the micro- and nanoscale.

We are proudly presenting BLUM Germany GmbH  as second exhibitor at the ISTEGIM Symposium.

BLUM Germany GmbH develops, produces and sells electronic components (power supplies and inductors) for power electronics for industrial and medical applications.

BLUM also represents SHINEI TECNO (Japan) , manufacturer for micro-scaled devices for microfluidic.

As a first Exhibitor for the ISTEGIM Symposium, Actphast  could be recruited. ACTPHAST provides photonics and non-photonics companies and researchers with one-stop-shop access to a wide range of existing cutting edge photonics technology platforms from Europe's top research centres

MDPI will act as Mediapartner of the ISTEGIM Symposium. A pioneer in scholarly open access publishing, MDPI has supported academic communities since 1996. Based in Basel, Switzerland, MDPI has the mission to foster open scientific exchange in all forms, across all disciplines. Their 203 diverse, peer-reviewed, open access journals are supported by over 35,500 academic editors.

Micromachines (ISSN 2072-666X) is a peer-reviewed open access journal on the science and technology of small structures, devices and systems, published monthly online by MDPI. Micromachines is indexed in EI, Scopus, PubMed and Web of Science, and has an Impact Factor of 2.222 (2017). Micromachines boasts a fast peer-review process and online publishing of original results. Manuscripts are peer-reviewed and a first decision provided to authors approximately 16 days after submission; acceptance to publication is undertaken in 5.2 days ((median values for papers published in this journal in the second half of 2018).